TCL Archive In Brief: City of Hope launches Hematologic Malignancies and Stem Cell Transplantation Institute October 31, 2014
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Cancer Groups Support Senate FDA Bill; Reform Measure Face Uncertain future March 1, 1996
TCL Archive NCI Advisors Ok Study of Cancer In Farmers; Commit $6.6 Million to Five Year Contracts April 3, 1992